GINA WANG: Open Payments
NPI 1518673177 · INGLEWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 52 payments from 13 companies in 2025. Trend: 2023 $240 · 2024 $514 · 2025 $1,495
Food & beverage: $1,495
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $327 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $283 |
| GlaxoSmithKline, LLC. | 9 | $259 |
| Kowa Pharmaceuticals America, Inc. | 7 | $247 |
| Verona Pharma, Inc. | 4 | $128 |
| Exact Sciences Corporation | 2 | $51 |
| Corcept Therapeutics | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $19 |
Products named: Kerendia, ZORYVE, Ozempic, SHINGRIX, Ohtuvayre, AREXVY, Cologuard Collection Kit, Korlym.
Industry payments across CA — which companies pay providers there.
